# clm_E5421E95D3E6

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: revenue  
value: 14,342,900,000 United States dollar  
valid_from: 2025-12-31  
valid_to: null  
published: 2026-02-04  
recorded: 2026-11-08  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals revenue: 14,342,900,000 United States dollar", as of 2025-12-31. Claim clm_E5421E95D3E6, https://asof.is/claim/clm_E5421E95D3E6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2025, filed 2026-02-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm (primary, SEC EDGAR 10-K FY2025, published 2026-02-04)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 14,202,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md) | [clm_EE95AAD2339E](/claim/clm_EE95AAD2339E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.